Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jiangsu Yingke Biopharmaceutical

Request full access

Specialized biopharmaceutical manufacturer of injectable generic drugs

ChinaFounded 2011Biotech & Life Sciences

About Jiangsu Yingke Biopharmaceutical

Jiangsu Yingke Biopharmaceutical Co., Ltd. is a biopharmaceutical company established on January 25, 2011, that integrates research and development, manufacturing, and sales. The company is located in the Taizhou National Medical Hi-tech Development Zone, also known as China Medical City.

The firm specializes in the R&D of products in fields including parenteral nutrition, anesthesia, and oncology. It focuses on creating fat emulsion series products, such as its Propofol Medium and Long Chain Fat Emulsion Injection, which was the first of its kind to be approved in China and was selected for the national centralized drug procurement program. Its product lineup also includes both launched and pre-launch drugs like Propofol Injectable Emulsion and various anesthetic creams. The company's business model combines in-house R&D with manufacturing and sales, aiming to become a key player in the fat emulsion segmentation market. Many of its products are listed in the National Essential Drug Catalog.

Jiangsu Yingke Biopharmaceutical operates multiple workshops compliant with new Good Manufacturing Practice (GMP) standards, including facilities for bulk drugs, freeze-dried powder injections, and both small and large-volume injections. Since its inception, the company has achieved significant milestones, passing its first GMP certification in 2013 and being recognized as a "National high-tech Enterprise" in 2015. In June 2023, the company secured $42.2 million in a Series B funding round.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jun 2023 $41M $165M Sherpa Venture Partners · China Life Private Equity Investment · Xinshang Capital · North Venture Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Jiangsu Yingke Biopharmaceutical website traffic

Latest recorded traffic for Jiangsu Yingke Biopharmaceutical is 1.3K monthly website visits, up 6400% over the last three months.

Latest monthly visits1.3K 3-month web change+6400%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Jiangsu Yingke Biopharmaceutical in its local ecosystem

Live from Dealroom

The Jiangsu Yingke Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Sherpa Venture Partners
  • China Life Private Equity Investment
  • Xinshang Capital
  • North Venture Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jiangsu Yingke Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jiangsu Yingke Biopharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.